Zobrazeno 1 - 10
of 948
pro vyhledávání: '"G, Rossoni"'
Publikováno v:
ESGE Days 2022.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C. Bonifacio, R Finotto, G. Mazzola, Paolo Andrea Zucali, Claudio Bordignon, Armando Santoro, Luca Balzarini, Monica Bertossi, F. De Vincenzo, Matteo Perrino, I Timofeeva, Elena Lorenzi, Matteo Simonelli, S. Naimo, Antonio Lambiase, G. Rossoni
Publikováno v:
British Journal of Cancer
Background: NGR–hTNF exploits the peptide asparagine–glycine–arginine (NGR) for selectively targeting tumour necrosis factor (TNF) to CD13-overexpressing tumour vessels. Maximum-tolerated dose (MTD) of NGR–hTNF was previously established at 4
Autor:
Federico Caligaris-Cappio, Lorenza Rimassa, Armando Santoro, Catia Traversari, Giovanni Citterio, Valeria Andretta, Chiara Miggiano, A. Pessino, Claudio Bordignon, Antonio Lambiase, Maria Chiara Tronconi, Carlo Carnaghi, Giovanna Finocchiaro, Gian Paolo Rizzardi, Angela Zanoni, G. Rossoni, Francesco Sclafani, Alberto Sobrero, F. Caprioni
Publikováno v:
European Journal of Cancer. 46:2746-2752
Background NGR-hTNF consists of human tumour necrosis factor (hTNF) fused with the tumour-homing peptide Asp-Gly-Arg (NGR), which is able to selectively bind an aminopeptidase N overexpressed on tumour blood vessels. Preclinical antitumour activity w
Autor:
Vagner G. Cortez, Maria G. Rossoni
Publikováno v:
International journal of medicinal mushrooms. 16(3)
A case of mushroom poisoning of a dog caused by a phalloid fungus is reported for the first time. The phalloid caused gastrointestinal syndrome in a 1-year-old dog, and was identified as Lysurus cruciatus, a common phalloid fungus in southern Brazil.
Autor:
Elena Brioschi, G. Rossoni, Maria Grazia Viganò, Scialini Colombi, Giulia Salini, Claudio Bordignon, Giovanna Petrella, Vanesa Gregorc, Luca Gianni, Giovanni Citterio, Alessandra Bulotta, Veronica Savia, Monika Ducceschi, Antonio Lambiase
Publikováno v:
Journal of Clinical Oncology. 34:e20077-e20077
e20077Background: In the NGR015 trial, patients failing a pemetrexed-based regimen were randomly assigned to weekly NGR-hTNF (N; n = 200) or placebo (P; n = 200), both given with BIC that included ...
Autor:
Maria Grazia Viganò, Claudio Bordignon, Giovanni Citterio, Elena Brioschi, Giovanna Petrella, Antonio Lambiase, Emma Redaelli, Monika Ducceschi, Giulia Salini, Luca Gianni, Vanesa Gregorc, G. Rossoni, Alessandra Bulotta, Scialini Colombi
Publikováno v:
Journal of Clinical Oncology. 34:e20075-e20075
e20075Background: NGR-hTNF selectively binds to CD13-expressing blood vessels and improves intratumor T-lymphocyte infiltration and CT uptake. CD13 expression is upregulated by tumor hypoxia/angiog...
Autor:
Shannon, Adrienne B.1 (AUTHOR) adrienne.shannon@moffitt.org, Zager, Jonathan S.1 (AUTHOR), Perez, Matthew C.1 (AUTHOR) matthew.perez@moffitt.org
Publikováno v:
Cancers. Jul2024, Vol. 16 Issue 13, p2395. 20p.
Autor:
Francesca Pozzi, Scialini Colombi, Nicola Personeni, Giovanni Citterio, Claudio Bordignon, Federico Caligaris-Cappio, G. Rossoni, Silvia Bozzarelli, F. de Braud, Tiziana Pressiani, Lorenza Rimassa, Armando Santoro, Giovanni Donadoni, Antonio Lambiase
Publikováno v:
British Journal of Cancer
Background: Hepatocellular carcinoma (HCC) is a highly vascularised and poor-prognosis tumour. NGR-hTNF is a vascular-targeting agent consisting of human tumour necrosis factor-alpha fused to the tumour-homing peptide NGR, which is able to selectivel